Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02411630 · ClinicalTrials.gov registry record
Factors Affecting PrEP Adherence
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 167
- Enrollment target
NCT02411630 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 167 participants.
The verdict
NCT02411630 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 167 participants
- Enrollment target
Study Summary
The purpose of this study is to test a new way to take a questionnaire that asks about adherence (whether the person is taking the medicine correctly). This new questionnaire is called Interactive Questionnaire System (iQS). In this study, the iQS will be tested on HIV-negative young men who have sex with men (YMSM) who are taking PrEP as part of another study, either ATN 110 or ATN 113.
Interventions
- DRUG Emtricitabine/tenofovir disoproxil
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2013-06 |
| Est. Completion | 2015-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02411630
The ClinicalTrials.gov registry entry for NCT02411630 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 167 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Emtricitabine/tenofovir disoproxil is the first listed.
NCT02411630 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02411630 about?
NCT02411630 is a clinical study titled "Factors Affecting PrEP Adherence". The purpose of this study is to test a new way to take a questionnaire that asks about adherence (whether the person is taking the medicine correctly). This new questionnaire is called Interactive Questionnaire System (iQS). In this study, the iQS will be tested on HIV-negative young men who have se...
What is the current status of trial NCT02411630?
This trial is currently completed. The enrollment target is 167 participants. The study started on 2013-06. Estimated completion is 2015-06.
What interventions are being tested in trial NCT02411630?
The interventions under investigation include: Emtricitabine/tenofovir disoproxil (DRUG).
Who is sponsoring clinical trial NCT02411630?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.